MIB1 and breast cancer: In the light of the important prognostic and predictive role of proliferative activity in breast cancer, it is not surprising that immunohistochemical detection of Ki-67 using the MIB-1 antibody has gained increasing importance in routine breast cancer diagnosis and has recently been recommended by the St.Gallen consensus conference [10], [11].